Le Lézard
Classified in: Health
Subjects: NPT, POL, AVO

Ohio Roundtable Responds to the Election Result on Ohio Issue 1


CLEVELAND, Nov. 8, 2023 /PRNewswire/ -- "Today's vote was a victory for George Soros, Arabella Advisors and the progressive cartel that paid over $40 million to buy a piece of the Ohio Constitution for their allies at Planned Parenthood," stated David Zanotti, President & CEO of the American Policy Roundtable.

"Because Issue One is an unsustainable amendment, the Ohio Roundtable is calling for immediate hearings in the Ohio Legislature to address the ramifications of the more than 50 state laws, which conflict with the new Article I, Section 22 of the Ohio Constitution. We are also asking the Ohio General Assembly to immediately pass a joint resolution to replace and repeal Section 22 with a more reasonable framework in the 2024 November election" stated Rob Walgate, Ohio Roundtable's Vice-President.  "This will provide a fair opportunity to clarify the Ohio laws that were intentionally misrepresented in this election."

The American Policy Roundtabletm was founded in 1980 in Ohio. APRtm is a non-profit, non-partisan independent public policy organization that supports no political parties or candidates. American Policy Roundtabletm is the parent company of Ohio Roundtabletm, and The Public Square® Media Network which produces radio, video and online programs broadcast daily on over 200 stations coast-to-coast. 

Related Links

http://www.aproundtable.org

https://seethelanguage.com

SOURCE The American Policy Roundtable


These press releases may also interest you

at 04:19
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide (fostrox) + Lenvima® in...

at 04:15
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line development service. There are now two ways for customers to...

at 04:07
Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion app in...

at 04:00
Calibre Scientific is pleased to announce the acquisition of Camlab Limited ("Camlab" or the "Company"), a UK-based supplier of scientific equipment, chemicals, consumables, labware, and other laboratory supplies and services to customers in the...

at 04:00
Hurom, a pioneer in the development of the slow juicer and a leader in the global market, is stepping up efforts to safeguard patent rights worldwide to protect its proprietary technology and contribute to a healthy industry ecosystem. Despite...

at 03:46
Allied Market Research published a report titled, "Biosimilar Testing and Development Services Market Share, Size, Competitive Landscape and Trend Analysis Report by Type, by End User: Global Opportunity Analysis and...



News published on and distributed by: